Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study

NCT04936282 is registered in ClinicalTrials.gov with Fundación Canaria Instituto de Investigación Sanitaria de Canarias as lead sponsor.

NCT NCT04936282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04936282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study
Lead sponsor
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Phase
Phase 4
Overall status
Active, not recruiting
Start date
July 5, 2022
Completion date
June 30, 2027
Enrollment
80 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure and rejection